Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 39.34 M42.1 M39.32 M40.25 M174 M79 M 332.56 M Research & development —————— — Operating income 276.29 M294.91 M246.48 M182.52 M-298 M1.5 B 1.63 B Non-Operating Income, Total -17.24 M78.28 M45.4 M71.56 M-696 M276 M -303.04 M Interest expense, net of interest capitalized 44.37 M42.56 M42.94 M43.06 M113 M111 M 310 M Non-Operating Income, excl. Interest Expenses -61.59 M35.75 M2.54 M28.42 M-810 M161 M -618.04 M Unusual income/expense -27 K-27 K-80 K80 K1 M4 M 5 M Pretax income 232 M252.5 M204.29 M140.71 M-410 M1.39 B 1.32 B Equity in earnings —————— — Taxes 49.73 M50.84 M49.2 M31.8 M-75 M318 M 324 M Non-controlling/minority interest —————— — After tax other income/expense -1.51 M6.21 M2.89 M22.11 M28 M10 M 63 M Net income before discontinued operations 182.27 M201.66 M155.09 M108.91 M-335 M1.07 B 1 B Discontinued operations —————— — Net income 182.27 M201.66 M155.09 M108.91 M-335 M1.07 B 1 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 182.27 M201.66 M155.09 M108.98 M-335 M1.07 B 1 B Basic earnings per share (Basic EPS) 1.591.761.350.95-1.684.48 5.1 Diluted earnings per share (Diluted EPS) 1.591.761.350.94-1.684.46 5.07 Average basic shares outstanding 114.52 M114.52 M114.83 M115 M199 M239 M — Diluted shares outstanding 114.95 M114.79 M115.23 M115 M199 M240 M — EBITDA 278.84 M297.46 M249.03 M183.86 M-303 M1.49 B 1.62 B EBIT 276.29 M294.91 M246.48 M181.52 M-298 M1.5 B 1.63 B Cost of revenue 225.07 M224.01 M229.04 M206.88 M428 M556 M 1.42 B Other cost of goods sold 225.07 M224.01 M229.04 M206.96 M428 M556 M 1.42 B Depreciation & amortization (cash flow) 2.55 M2.55 M2.55 M2.35 M-5 M-5 M -5.1 M